Clinical trial
Montelukast Compared With Placebo and Salmeterol in Exercise-Induced…
NCT00245570 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00245570 |
|---|---|
| Title | Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316) |
| Official title | A Double-Blind, Randomized Multicenter, 3-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast Compared With Placebo and Salmeterol on Exercise-Induced Bronchoconstriction |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma, Exercise-Induced |
| Intervention type | Drug |
| Interventions | Comparator: Montelukast, Comparator: Salmeterol, Comparator: Placebo (montelukast), Comparator: Placebo (salmeterol) |
| Enrollment | 47 |
| Start date | Dec 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Oct 28, 2005 |
| Last update posted | Feb 2, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: